Search hospitals

>

Montana

>

Great Falls

Great Falls Clinic

Claim this profile

Great Falls, Montana 59405

Global Leader in Breast Cancer

Global Leader in Lung Cancer

Conducts research for Breast cancer

Conducts research for Cancer

Conducts research for Pancreatic Cancer

450 reported clinical trials

2 medical researchers

Photo of Great Falls Clinic in Great FallsPhoto of Great Falls Clinic in Great FallsPhoto of Great Falls Clinic in Great Falls

Summary

Great Falls Clinic is a medical facility located in Great Falls, Montana. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Great Falls Clinic is involved with conducting 450 clinical trials across 487 conditions. There are 2 research doctors associated with this hospital, such as John M. Schallenkamp and Benjamin T. Marchello.

Area of expertise

1

Breast Cancer

Global Leader

Great Falls Clinic has run 83 trials for Breast Cancer. Some of their research focus areas include:

ER positive
Stage IV
HER2 negative
2

Lung Cancer

Global Leader

Great Falls Clinic has run 62 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage II
Stage I

Top PIs

Clinical Trials running at Great Falls Clinic

Bladder Cancer

Lung Cancer

Prostate Cancer

Breast Cancer

Breast cancer

Ovarian Cancer

Esophageal cancer

Bladder Carcinoma

Pancreatic Cancer

Multiple Myeloma

Image of trial facility.

Gemcitabine + BCG

for Bladder Cancer

This phase III trial compares the effect of adding gemcitabine to intravesical Bacillus Calmette Guerin (BCG) versus intravesical BCG alone in patients with non-muscle invasive bladder cancer that has come back after a period of improvement (recurrent). Gemcitabine is a chemotherapy drug that blocks the cells from making deoxyribonucleic acid (DNA) and may kill cancer cells. Intravesical BCG is a solution containing the live BCG bacteria that is placed in the bladder via a catheter (intravesical). When the solution comes into direct contact with the bladder wall, it stimulates the body's immune system which kills tumor cells. Giving gemcitabine with intravesical BCG may kill more tumor cells in patients with recurrent non-muscle invasive bladder cancer.

Recruiting

2 awards

Phase 3

10 criteria

Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.

Recruiting

2 awards

Phase 3

Image of trial facility.

Gemcitabine + Docetaxel vs BCG

for Bladder Cancer

This trial is testing whether a combination of two drugs, Gemcitabine and Docetaxel, given directly into the bladder, is effective for patients with high-grade non-muscle invasive bladder cancer who have not been treated with the standard therapy before. The goal is to see if this new treatment can prevent cancer from coming back or spreading. The study will also look at the quality of life, safety, and side effects of the new treatment. Gemcitabine and Docetaxel have shown promise as an alternative treatment, especially in cases where the standard therapy fails or is not tolerated.

Recruiting

2 awards

Phase 3

14 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Great Falls Clinic?

Where is Great Falls Clinic located?

Who should I call to ask about financial aid or insurance network?

What insurance does Great Falls Clinic accept?

What awards or recognition has Great Falls Clinic received?